Efficacy and Safety of Omalizumab in Bullous Pemphigoid

NCT00472030 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

2

Enrollment

OTHER

Sponsor class

Conditions

Bullous Pemphigoid

Interventions

DRUG: Omalizumab
DRUG: prednisone

Sponsor

University of Iowa

Collaborators

[object Object]